Considering the complexity of PDAC architecture, the true “invasive front” of a tumor cannot be reliably identified in a 2-dimensional tissue section, so we could not determine whether SPOCK1 or OLR1 expression was enhanced in the most invasive PDAC cells in vivo. The gene discussed is OLR1; the disease is neoplasm.